Carregant...
Denosumab treatment in the management of patients with advanced prostate cancer: clinical evidence and experience
Osteoprotective therapies have become an essential component in the management of advanced prostate cancer (PC) patients as bone metastases (BMs) have a major impact on morbidity and mortality. Denosumab is a fully humanized antibody targeting the receptor activator of nuclear factor κB ligand (RANK...
Guardat en:
| Publicat a: | Ther Adv Urol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5378096/ https://ncbi.nlm.nih.gov/pubmed/28392837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287216686018 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|